FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
Deng C, Zhang B, Zhang S, Duan C, Cao Y, Kang W, et al
Its important to choose a provider who knows when to say no to prevent aggravating puffiness or sagging of this delicate area
Frequently Asked Questions Q1: Can glutathione fix a hormonal imbalance
There are no one size fits all plans
Peptides support but do not replace the work of building exercise tolerance